For-Profit Trials Show Positive Outcomes More Often Than Non-Profits, JAMA Study Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysis finds 49% of trials sponsored by non-profits favored newer treatments compared to 67.2% of trials funded by for-profit organizations.
You may also be interested in...
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.